Home › Alzheimer's Disease › Florida › The Villages
Alzheimer's Disease clinical trials in The Villages, FL
15 studies for Alzheimer's Disease are looking for participants at sites in and around The Villages (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
RecruitingPhase 1Healthy volunteers welcome
- Local Institution - 0006, The Villages
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
RecruitingPhase 2
- Charter Research - Lady Lake- Site Number : 8400004, The Villages
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
RecruitingPhase 3
- Charter Research, The Villages
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RecruitingPhase 3
- Charter Research - Lady Lake/The Villages, The Villages
- K2 Medical Research - The Villages, Lady Lake · 3 mi away
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
RecruitingPhase 1/2
- K2 Medical Research - The Villages /ID# 278290, Lady Lake · 3 mi away
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
RecruitingPhase 3
- Local Institution - 0129, The Villages
- K2 MEDICAL Research THE VILLAGES, Lady Lake · 3 mi away
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
RecruitingPhase 2
- Charter Research - Lady Lake, The Villages
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
RecruitingPhase 2
- Charter Research - Lady Lake ( Site 1019), The Villages
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
RecruitingPhase 1
- Charter Research, LLC, The Villages
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
RecruitingPhase 3
- Charter Research - Lady Lake, The Villages
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
RecruitingPhase 1/2
- Charter Research, LLC, The Villages
- K2 Medical Research The Villages LLC, Lady Lake · 3 mi away
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
RecruitingPhase 3
- Charter Research - The Villages, The Villages
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
RecruitingPhase 2
- Charter Research The Villages, The Villages
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
RecruitingPhase 1Healthy volunteers welcome
- K2 Medical Research - The Villages, Lady Lake · 3 mi away
[18F]PI-2620 Phase 3 Histopathological Study
RecruitingPhase 3
- K2 Medical Research, Lady Lake · 3 mi away
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Boston, MA26 studies
- Orlando, FL25 studies
- St. Louis, MO22 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Tampa, FL17 studies
- Atlanta, GA16 studies
- Philadelphia, PA15 studies
- Phoenix, AZ15 studies
- Indianapolis, IN14 studies
- Los Angeles, CA14 studies
- West Palm Beach, FL13 studies
Other studies in The Villages
- Obesity9 studies
- Overweight8 studies
- Dementia6 studies
- Mild Cognitive Impairment4 studies
- Steatotic Liver Disease3 studies
- Parkinson's Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.